If you are a member of the press looking for information on AYOXXA Biosystems, the following are a collection of print and video materials that provide an overview of our company mission, scientific and business achievements, and roadmap looking into the future.
Please contact us if you require further assistance.
This collection of news releases regarding products, collaborations, and events is kept current and serves as a first stop to read up on developments at AYOXXA.
AYOXXA launches LUNARIS™ Human 11-Plex Ophthalmology Kit
For multiplexed analysis of biomarker signatures in ocular fluids including vitreous and aqueous samples. Covering: angiogenic & inflammatory factors, chemokines known to be relevant in the pathology of retinal angiogenic diseases next to VEGF, the target molecule of today’s standard of care.Read more
AYOXXA develops multiplex assay for stratification of sepsis patients using soluble biomarkers
AYOXXA Biosystems GmbH joined "SepsisDataNet.NRW" research project funded by EFRE and comprises a consortium of NRW companies, university hospitals and universities. Funding started in July 2017 for a period of three years.Read more
AYOXXA launches LUNARIS Mouse 12-Plex Th17 Kit to elucidate Th17 cell biology
LUNARIS™ Mouse 12-Plex Th17 Kit comprises highly specific reagents for the quantitative analysis of soluble markers of Th17 cell biology Kit includes the primary Th17 related cytokines involved in autoimmune disorders, immune-mediated diseases as well as asthma, allergy, cancer, microbial defense and transplantation Launch marks a further step in establishing AYOXXA’s LUNARIS™ as the technology of choice for fully scalable beads-on-a-chip multiplRead more
AYOXXA introduces LUNARIS™, its advanced fully integrated low-volume beads-on-a-chip multiplex protein analysis system
AYOXXA Biosystems GmbH, an international biotechnology company, today announces the introduction of its advanced low-volume beads-on-a-chip multiplex protein analysis system. The LUNARIS™ system can be readily integrated into any laboratory routine and is optimized to provide easy-to-use, standardized workflow from sample to result.Read more
AYOXXA is Member of the International EYE-RISK Consortium
Cologne 22 October 2015 - AYOXXA Biosystems GmbH, an international biotechnology company, is one of two industrial partners of EYE-RISK, a large biomedical consortium bringing together the expertise of ten renown scientific and clinical institutions and a patient organization from six European countries. It is led by Prof. Dr.Read more
Collaboration between AYOXXA and the Singapore Eye Research Institute
Singapore 2 March 2015 - AYOXXA, an international biotech company with headquarters in Cologne, has signed an agreement with the Singapore Eye Research Institute (SERI), one of the leading international eye research institutes. AYOXXA and SERI will work together on validating the company’s multiplexing technology platform for protein biomarker detection, as part of an expanded collaboration for developing ophthalmic diagnostic tools.Read more
Watch professionally edited videos showcasing the LUNARIS™ Technology and explaining our vision to enable success in translational research.